These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10999114)

  • 1. Fenugreek in diabetes mellitus.
    Puri D
    J Assoc Physicians India; 1999 Feb; 47(2):255-6. PubMed ID: 10999114
    [No Abstract]   [Full Text] [Related]  

  • 2. Fenugreek in diabetes mellitus.
    Pavithran K
    J Assoc Physicians India; 1994 Jul; 42(7):584. PubMed ID: 7868541
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic applications of fenugreek.
    Basch E; Ulbricht C; Kuo G; Szapary P; Smith M
    Altern Med Rev; 2003 Feb; 8(1):20-7. PubMed ID: 12611558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled study.
    Gupta A; Gupta R; Lal B
    J Assoc Physicians India; 2001 Nov; 49():1057-61. PubMed ID: 11868855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potentials of fenugreek.
    Puri D
    Indian J Physiol Pharmacol; 1998 Jul; 42(3):423-4. PubMed ID: 9741661
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucose-lowering effect of fenugreek in non-insulin dependent diabetics.
    Madar Z; Abel R; Samish S; Arad J
    Eur J Clin Nutr; 1988 Jan; 42(1):51-4. PubMed ID: 3286242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of a hypoglycemic principle isolated from fenugreek seeds.
    Puri D; Prabhu KM; Murthy PS
    Indian J Physiol Pharmacol; 2002 Oct; 46(4):457-62. PubMed ID: 12683221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotoxicity testing of a fenugreek extract.
    Flammang AM; Cifone MA; Erexson GL; Stankowski LF
    Food Chem Toxicol; 2004 Nov; 42(11):1769-75. PubMed ID: 15350674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ACCORD Trial and control of blood glucose level in type 2 diabetes mellitus: time to challenge conventional wisdom.
    Havas S
    Arch Intern Med; 2009 Jan; 169(2):150-4. PubMed ID: 19171811
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical investigation of hypoglycemic effect of seeds of Azadirachta-inidca in type-2 (NIDDM) diabetes mellitus.
    Waheed A; Miana GA; Ahmad SI
    Pak J Pharm Sci; 2006 Oct; 19(4):322-5. PubMed ID: 17105712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counterpoint: A Diabetes Outcome Progression Trial (ADOPT): good for sulfonylureas?
    Al-Ozairi E; Sibal L; Home P
    Diabetes Care; 2007 Jun; 30(6):1677-80. PubMed ID: 17351288
    [No Abstract]   [Full Text] [Related]  

  • 12. An overview of incretin clinical trials.
    Garber AJ; Spann SJ
    J Fam Pract; 2008 Sep; 57(9 Suppl):S10-8. PubMed ID: 18786339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary evaluation of the hypoglycemic effect of some Brazilian medicinal plants.
    Novaes AP; Rossi C; Poffo C; Pretti Júnior E; Oliveira AE; Schlemper V; Niero R; Cechinel-Filho V; Bürger C
    Therapie; 2001; 56(4):427-30. PubMed ID: 11677867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of glitazones on the progression of type 2 diabetes and on cardiovascular endpoints].
    Schatz H
    Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1825-30. PubMed ID: 16052448
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized controlled clinical trial evaluating the effect of
    Najdi RA; Hagras MM; Kamel FO; Magadmi RM
    Afr Health Sci; 2019 Mar; 19(1):1594-1601. PubMed ID: 31148988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved alpha-amylase and Helicobacter pylori inhibition by fenugreek extracts derived via solid-state bioconversion using Rhizopus oligosporus.
    Randhir R; Shetty K
    Asia Pac J Clin Nutr; 2007; 16(3):382-92. PubMed ID: 17704018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opinion: Tight blood glucose control and cardiovascular disease in the elderly diabetic? Let the randomized controlled trials speak for themselves.
    Sherman FT
    Geriatrics; 2008 Aug; 63(8):8-10. PubMed ID: 18672951
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascular and renal benefits are additive using intensive blood pressure control and incremental glucose control in type 2 diabetic patients.
    Cardiovasc J Afr; 2008; 19(5):284-6. PubMed ID: 18997995
    [No Abstract]   [Full Text] [Related]  

  • 19. Thiazolidinediones--a means to endpoint intervention.
    Jerkins TW
    Tenn Med; 2000 Nov; 93(11):403-5. PubMed ID: 11077884
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of blood glucose by plant extracts and their use in the treatment of diabetes mellitus; discrepancies in effectiveness between animal and human studies.
    Furman BL; Candasamy M; Bhattamisra SK; Veettil SK
    J Ethnopharmacol; 2020 Jan; 247():112264. PubMed ID: 31600561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.